Yale Study: Tariff Policies Will Cause U.S. Prices to Rise by 1.8% in the Short Term
According to a report by Jinse Finance, the U.S. government's tariff policy has triggered months of ongoing volatility in the American economy. On the 29th, U.S. media cited research data indicating that the tariff policy will cause U.S. prices to rise by 1.8% in the short term, which is close to the Federal Reserve's 2% inflation control target.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Equinix (EQIX.US) chosen as the top stock for Citi’s data centers: AI integration accelerates in one year what took the cloud seven years, making interconnected networks the biggest winners
Citigroup maintains a "Buy" rating on Equinix and lists it as a top pick, expecting its recurring revenue to accelerate to 13% by 2027, with a target price of $1,320.

Japan's 20-year government bond auction sees weak demand as bid-to-cover ratio drops sharply to 3.64, marking the lowest demand of the year
Japan's 20-year government bond auction saw weak demand, with the bid-to-cover ratio falling to 3.64 and the tail widening to its largest in a year. The market is concerned about fiscal budget issues and rising yields.

Google-backed AI pharmaceutical company raises $5 billion in funding, doubling the previous round
The current funding round for Isomorphic Labs is co-led by top VCs including Sequoia Capital and Andreessen Horowitz. This round comes only six months after the previous $2.1 billion Series B, with the scale more than doubling. By 2026, total financing in the AI pharmaceutical sector has reached a record high of $23.2 billion, with Anthropic and OpenAI also entering the field.
Japanese stocks closed up by 0.28%

